American Century Companies’s BioAge Labs BIOA Stock Holding History

American Century Companies’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	54,780 +25,877	+90%	+$467K	﹤0.01%	2322
2026 Q1	$506K	Buy	+28,903	New	+$557K	﹤0.01%	2512

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Topco New York $245B AUM

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

American Century Companies's BIOA Position: Q2 2026 in Review

American Century Companies increased its BioAge Labs (BIOA) stake by 90% in Q2 2026, buying an estimated $467K and bringing the position to 54,780 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

American Century Companies first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

American Century Companies held 54,780 shares of BioAge Labs worth $1.34M as of Q2 2026.
American Century Companies bought 25,877 BioAge Labs shares in Q2 2026, an estimated $467K.
BioAge Labs made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2322 holding.
American Century Companies first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.